Prevalence of hepatitis B virus coinfection among Human Immunodeficiency Virus positive patients in Yola, Adamawa State, Nigeria
SALE, M., Bagarmi, A., Yunana, S. (2022). Prevalence of hepatitis B virus coinfection among Human Immunodeficiency Virus positive patients in Yola, Adamawa State, Nigeria. EKB Journal Management System, 3(1), 48-54. doi: 10.21608/mid.2021.64091.1126
MUSA SALE; Amira Bagarmi; Shinjawa Yunana. "Prevalence of hepatitis B virus coinfection among Human Immunodeficiency Virus positive patients in Yola, Adamawa State, Nigeria". EKB Journal Management System, 3, 1, 2022, 48-54. doi: 10.21608/mid.2021.64091.1126
SALE, M., Bagarmi, A., Yunana, S. (2022). 'Prevalence of hepatitis B virus coinfection among Human Immunodeficiency Virus positive patients in Yola, Adamawa State, Nigeria', EKB Journal Management System, 3(1), pp. 48-54. doi: 10.21608/mid.2021.64091.1126
SALE, M., Bagarmi, A., Yunana, S. Prevalence of hepatitis B virus coinfection among Human Immunodeficiency Virus positive patients in Yola, Adamawa State, Nigeria. EKB Journal Management System, 2022; 3(1): 48-54. doi: 10.21608/mid.2021.64091.1126

Prevalence of hepatitis B virus coinfection among Human Immunodeficiency Virus positive patients in Yola, Adamawa State, Nigeria

Microbes and Infectious Diseases
Article 6, Volume 3, Issue 1, February 2022, Page 48-54  XML PDF (296.8 K)
Document Type: Original Article
DOI: 10.21608/mid.2021.64091.1126
View on SCiNiTO View on SCiNiTO
Authors
MUSA SALE email 1; Amira Bagarmi2; Shinjawa Yunana3
1Department of Microbiology, Modibbo Adama University of Technology, Yola, Nigeria
2Department of Microbiology, School of life Sciences Modibbo Adama University of Technology, Yola, Nigeria
3Pathology Department, Adamawa State Specialist Hospital Yola, Nigeria
Abstract
Background: Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) confection has been reported to impair negatively on the health of the patients because it impacts directly on the outcome of HBV infection, considerably complicating its natural history, diagnosis and management. This study was aimed at determining the incidence and distribution of HBV/HIV coinfection in the study area. Methods: The sera people living with HIV/AIDS were screened for hepatitis B surface antigen (HBsAg) and cluster of differentiation 4 (CD4) cell counts using the Becton Dickinson Fluorescence Activated Cell Sorter procedure. Results: The prevalence of HBV co-infection among people living with HIV/AIDS in this study was 11% with the coinfection being higher in males (14.3%) compared to the 9.7% among females. The coinfection was highest among people ages 25-39 yr. (12.9%) while least occurrence of coinfection was observed in ages above 53 yr. (8.3%). The CD4 counts of HBV and HIV coinfected persons showed that 18.2% of coinfected persons had CD4 counts above 700-1000 cells/mm3 while 12.1% had CD4 counts between 501-700 cells/mm3. Conclusion: The relatively high prevalence of HBV infection in HIV patients confirms the need for baseline screening for these markers in HIV-infected patients, as this could affect the choice of highly active antiretroviral therapy (HAART) regimen for the patients.
Keywords
Coinfection; HBV; HIV; Distribution
Statistics
Article View: 393
PDF Download: 359